Preclinical Research Supports Pridopidine’s Therapeutic Potential

Preclinical Research Supports Pridopidine’s Therapeutic Potential

297985

Preclinical Research Supports Pridopidine’s Therapeutic Potential

Treatment with pridopidine rescues the function of mitochondria — the cell’s powerhouses — boosting energy production, and reduces oxidative stress in models of Huntington’s disease, preclinical research shows. According to researchers, these findings support the therapeutic potential of pridopidine and its ongoing clinical development. Pridopidine is a small oral molecule being developed by Prilenia Therapeutics for the treatment of Huntington’s and other neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). The therapy is designed to enter the brain…

You must be logged in to read/download the full post.